Physician profile
Gerald A Lofthouse
NPI 1972551513
$773.51
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $265 · 2021: $87.15 · 2022: $84.97 · 2023: $91.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $468.34 | 2019-2023 | Evenity, Prolia |
| Novo Nordisk INC | $71.73 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $38.29 | 2023 | Gvoke Hypopen |
| Dexcom, INC. | $19.46 | 2020 | |
| Pfizer INC. | $19.27 | 2019 | |
| Exact Sciences Corporation | $18.95 | 2023 | Cologuard Collection Kit |
| Medtronic Minimed, INC. | $17.84 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.02 | 2020 | |
| Medtronic, INC. | $15.78 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.00 | 2021 | |
| Abbvie INC. | $14.11 | 2022 | |
| Esperion Therapeutics, INC. | $12.54 | 2021 | |
| Lilly USA, LLC | $12.36 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.75 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.17 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Lofthouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.